Neothetics Announces Last Subject Enrolled in Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat
March 20, 2017 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, March 20, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today announced...
Neothetics to Provide a Business Update and Release Fourth Quarter 2016 Financial Results Thursday, March 23, 2017
March 16, 2017 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, March 16, 2017 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it will provide a business update and release its fourth quarter 2016 financial results before the...
Neothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat
December 23, 2016 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Dec. 23, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced the initiation of the Phase 2 proof of concept trial, LIPO-202-CL-31, for LIPO-202 for the reduction of...
Neothetics Provides Business Update and Reports Third Quarter 2016 Financial Results
November 10, 2016 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided a business update on its strategic initiatives and reported financial results for the third quarter 2016. ...
Neothetics to Provide a Business Update and Release Third Quarter 2016 Financial Results Thursday, November 10, 2016
November 03, 2016 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that it will provide a business update and release its third quarter 2016 financial results before the...
Neothetics Provides Business Update and Reports Second Quarter 2016 Financial Results
August 11, 2016 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, Aug. 11, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided a business update on its strategic and operational initiatives and reported financial results for the...
Neothetics Reports First Quarter 2016 Financial Results
May 12, 2016 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, May 12, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today reported financial results and business progress for the first quarter 2016. First Quarter 2016 Highlights ...
Neothetics to Release First Quarter 2016 Financial Results
May 05, 2016 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, May 05, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
Neothetics to Present at the 15th Annual Needham Healthcare Conference
April 06, 2016 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, April 06, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today announced that Susan Knudson, Neothetics’ Chief Financial Officer, will present at the 15th Annual Needham...
Neothetics Provides Update and Plan Forward for LIPO-202 Program
March 28, 2016 08:00 ET
|
Neothetics, Inc.
SAN DIEGO, March 28, 2016 (GLOBE NEWSWIRE) -- Neothetics, Inc. (NASDAQ:NEOT) today provided an update and plan forward for its LIPO-202 program. Neothetics plans to initiate a Phase 2 trial with...